About 100 reports

China’s demand for Ovarian Cancer Treatment Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export,...

  • Ovarian Cancer
  • Chemotherapy
  • Targeted Therapy
  • China
  • Industrial Production
  • Labour Force

China’s demand for Breast Cancer Treatment Drug has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, import & export, consumer...

  • Breast Cancer
  • Chemotherapy
  • Targeted Therapy
  • China
  • Industrial Production
  • Labour Force

Global TROP2 Antibody Market & Clinical Trials Insight 2026 Report Analysis and Data Highlights: • Research Methodology • Global & Regional Market Analysis • Global TROP2 Antibody Market Opportunity Assessment: > USD 4 Billion • Market and Drug Sales Insight 2020 Till 2026 • Approved Drug In Market: 1 Drugs • Approved...

  • Pharmaceutical
  • Lung Cancer
  • Breast Cancer
  • Therapy
  • Biopharmaceutical
  • Clinical Trial
  • Immunotherapy
  • Targeted Therapy
  • World
  • Drug Approval

INTRODUCTION Human epidermal growth factor receptor 2 (HER2), a member of human epidermal growth factor receptor family, plays an important role in the development and progression of various types of cancers, especially breast cancer. Over time, it has been found to be an important target for the drug therapies intended...

  • Targeted Therapy
  • APAC
  • Europe
  • United States
  • Latin America
  • MENA
  • Drug Approval

INTRODUCTION Close to 10 million fatalities reported in 2020 were observed to be associated with cancer, which is believed to be one of the leading causes of death, globally. , One of the primary reasons for the high mortality rate associated with this condition is anticipated to be late diagnosis, which eventually results...

  • Targeted Therapy
  • Therapy
  • World
  • APAC
  • Drug Approval

Abstract: - Global Sarcoma Drugs Market to Reach $1.4 Billion by 2027 - Amid the COVID-19 crisis, the global market for Sarcoma Drugs estimated at US$871.4 Million in the year 2020, is projected to reach a revised size of US$1.4 Billion by 2027, growing at aCAGR of 7.1% over the period 2020-2027. Targeted Therapy,...

  • Cancer
  • Targeted Therapy
  • Chemotherapy
  • World
  • China
  • United States

Abstract: - Global Amyloidosis Treatment Market to Reach $6.5 Billion by 2027 - Amid the COVID-19 crisis, the global market for Amyloidosis Treatment estimated at US$4.3 Billion in the year 2020, is projected to reach a revised size of US$6.5 Billion by 2027, growing at a CAGR of 6% over the analysis period 2020-2027....

  • Endocrine Disease
  • Targeted Therapy
  • World
  • China
  • United States

Abstract: - Global Liver Diseases Treatment Market to Reach $27.2 Billion by 2027 - Amid the COVID-19 crisis, the global market for Liver Diseases Treatment estimated at US$13.6 Billion in the year 2020, is projected to reach a revised size of US$27.2 Billion by 2027, growing at a CAGR of 10.4% over the analysis period...

  • Digestive System Disorder
  • Targeted Therapy
  • World
  • China
  • United States

Global B Cell Maturation Antigen (BCMA) Targeted Therapy Market & Clinical Trials Insight 2026 Report Analysis and Data Highlights: • Research Methodology • Global & Regional Market Analysis • Global BCMA Targeted Drugs Market Opportunity Assessment: > USD 4 Billion • Market and Drug Sales Insight 2020 Till 2026 • Approved...

  • Immunotherapy
  • Cancer
  • Monoclonal Antibody
  • World
  • Drug Approval

The kidney cancer therapeutics & diagnostics market will show a rapid growth due to the rising number of kidney cancer cases and increased R&D expenditure of the pharmaceutical companies. - According to the GLOBOCAN, the incidence of Kidney cancer is 4.5 per 100,000 in 2018, worldwide. The 5 major countries contributing to the global...

  • Renal Cancer
  • Cancer
  • Diagnostics
  • Targeted Therapy
  • APAC
  • Europe
  • Africa
  • Smoking Prevalence
  • Cause-Specific Mortality Rate

Microbiome - Targeted Therapeutics in Immunology - Thematic Research Summary The microbiome is considered the genetic material of all microorganisms existing in and on the human body.Large resident microbial communities exist in the gastrointestinal (GI) tract, skin, and respiratory tract, and...

  • Pharmaceutical
  • Therapy
  • Dermatological Condition
  • Gastrointestinal Drug
  • Targeted Therapy
  • Clinical Trial
  • Acne Treatment
  • United States
  • Asthma Prevalence
  • Drug Approval

This study explores the global immuno-oncology (I-O) market’s evolution from 2020 to 2025. An extensive analysis is provided on the growth opportunities envisioned to help stakeholders leverage their momentum and disrupt the market by offering best-in-class solutions. The study considers oncology agents for which the immune system is the...

  • Infectious Disease
  • Targeted Therapy
  • Cancer Immunotherapy
  • Pharmaceutical
  • Gene Therapy
  • Monoclonal Antibody
  • Cell Therapy
  • World

Major players in the thyroid cancer drugs market are Mylan Pharmaceuticals Inc., Alara Pharmaceutical Corporation, Bristol Myers co., Teva parenteral medicines Inc., and Jerome Stevens Pharmaceuticals Inc. The global thyroid cancer drugs market is expected to grow from $0.4 billion in 2020 to $0.47 billion in 2021 at a compound annual...

  • Oncology
  • Targeted Therapy
  • World
  • United States
  • Drug Approval

Global MEK Inhibitors Market, Drug Sales & Clinical Trials insight 2026 Report Analysis & Data Highlights: • Research Methodology • Global & Regional Market Analysis • Global MEK Inhibitors Market Opportunity Assessment: > USD 3 Billion • Market & Drug Sales Insight 2020 Till 2026 • Approved Drug In Market: 4 Drugs •...

  • Clinical Trial
  • Targeted Therapy
  • World
  • Drug Approval

Global Gene Panel Market 2021-2025 The analyst has been monitoring the gene panel market and it is poised to grow by $ 2.17 billion during 2021-2025, progressing at a CAGR of almost 18% during the forecast period. Our report on the gene panel market provides a holistic analysis, market size and forecast, trends, growth...

  • Targeted Therapy
  • Genetic Disorder
  • Marketing Research
  • World

Major players in the breast cancer monoclonal antibodies (mAbs) market are Amgen, Mylan, Merck, Novartis, GlaxoSmithKline, Daiichi Sankyo, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb and Array BioPharma. The global breast cancer monoclonal antibodies market is expected to grow from $15.37 billion in 2021 to $16.67 billion in...

  • Breast Cancer
  • Monoclonal Antibody
  • World
  • Oncology Drug Sales
  • Cancer Mortality

Uveitis Treatment Market by Drug Class (Anti-inflammatory, Antimicrobial Drugs, Immunotherapy & Targeted Therapies, and Others), Disease Type (Anterior Uveitis, Posterior Uveitis, Intermediate Uveitis, and Panuveitis), and Distribution Channel (Hospital Pharmacy, Drug Store & Retail Pharmacy, and Online Providers): Global Opportunity...

  • Therapy
  • Antiseptics
  • Targeted Therapy
  • Analgesic
  • Pharmacy
  • World
  • APAC
  • Europe

This study focuses on China’s Ovarian Cancer Treatment Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Ovarian Cancer
  • Chemotherapy
  • Targeted Therapy
  • China
  • Labour Force
  • Industrial Production

This study focuses on China’s Breast Cancer Treatment Drug industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China’s society and economy. China is one of the...

  • Breast Cancer
  • Chemotherapy
  • Targeted Therapy
  • Cancer Hormonal Therapy
  • China
  • Labour Force
  • Industrial Production

Global Lice Treatment Market 2022-2026 The analyst has been monitoring the lice treatment market and it is poised to grow by $ 128.97 mn during 2022-2026, progressing at a CAGR of 6.26% during the forecast period. Our report on the lice treatment market provides a holistic analysis, market size and forecast, trends, growth...

  • Healthcare
  • Targeted Therapy
  • Marketing Research
  • In-Store Retail
  • World
  • Health Expenditure

Global Gene Panel Market: About this market This gene panel market analysis considers sales from small panel testing and large panel testing products. Our study also finds the sales of gene panels in Asia, Europe, North America, and ROW. In 2019, the small panel testing segment had a significant market share, and this...

  • Targeted Therapy
  • Oncology
  • Genetic Testing
  • World

INTRODUCTION Cancer is known to be one of the leading causes of death worldwide, accounting for 0.6 million deaths in 2018, in the US alone. The World Health Organization has estimated the number of new cancer cases, reported across the globe, to rise by 70% over the next 20 years. Conventional treatment options, such as...

  • Therapy
  • Targeted Therapy
  • Cancer
  • World
  • United States

Major players in the breast cancer monoclonal antibodies (mAbs) market are Amgen, Mylan, Merck, Novartis, GlaxoSmithKline, Daiichi Sankyo, Biocad, Boehringer Ingelheim, Bristol-Myers Squibb, and Array BioPharma. The global breast cancer monoclonal antibodies market is expected to grow from $12.67 billion in 2020 to $13.76 billion in...

  • Breast Cancer
  • Monoclonal Antibody
  • World
  • Oncology Drug Sales
  • Cancer Mortality

“AXL kinase inhibitors – Pipeline Insight, 2021,” report provides comprehensive insights about 22+ companies and 22+ pipeline drugs in AXL kinase inhibitors pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products. It also covers the therapeutics assessment by product type, stage, route of...

  • Targeted Therapy
  • World
  • United States

The global cancer monoclonal antibodies market exhibited moderate growth during 2015-2020. A cancer monoclonal antibody refers to a laboratory-generated molecule that is engineered to mimic the immune system’s attack on cancer cells. It can bind to antigens present on the surface of cancer cells and flag them to trigger...

  • Monoclonal Antibody
  • World

The global automated liquid handling market reached a value of US$ 910.1 Million in 2021. Looking forward, the analyst expects the market to reach a value of US$ 1,501.4 Million by 2027, exhibiting a CAGR of 8.40% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well...

  • Drug Development
  • Genomics
  • Genome Sequencing
  • Targeted Therapy
  • Robotics
  • World
  • Employment Costs

“Global Anaplastic Lymphoma Kinase ALK Inhibitors Market & Clinical Trials Insight 2026” Report Highlights: • Global ALK Inhibitors Market Opportunity: > USD 5 Billion • US Dominates Global ALK Inhibitors Market Sales: >30% • Approved ALK Inhibitors: 5 Drugs • Global & Regional ALK Inhibitors Market Sales Insights...

  • Targeted Therapy
  • World

Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Drugs in Development, 2021 Summary Cellular Tumor Antigen p53 (Tumor Suppressor p53 or Phosphoprotein p53 or Antigen NY CO 13 or TP53) - Drugs in Development, 2021 provides in depth analysis on Cellular...

  • Monoclonal Antibody
  • World

Cells Expressing Neural Cell Adhesion Molecule 1 (Antigen Recognized By Monoclonal Antibody 5.1H11 or CD56 or NCAM1) - Drugs in Development, 2021 Summary Cells Expressing Neural Cell Adhesion Molecule 1 (Antigen Recognized By Monoclonal Antibody 5.1H11 or CD56 or NCAM1) - Drugs in Development, 2021...

  • Monoclonal Antibody
  • World

Cells Expressing CD70 Antigen (CD27 Ligand or Tumor Necrosis Factor Ligand Superfamily Member 7 or CD70) - Drugs in Development, 2021 Summary Cells Expressing CD70 Antigen (CD27 Ligand or Tumor Necrosis Factor Ligand Superfamily Member 7 or CD70) - Drugs in Development, 2021 provides in depth analysis...

  • Monoclonal Antibody
  • World